Delivery Order SPE2DB22D2206-SPE2DB24FHX46

Award Date 6/25/24
Potential Completion Date 6/26/24
Potential Value $18K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, with ID SPE2DB20D2001|SPE2DB24FM42E, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $13,485.50 delivery order contract is for the supply of 4,563,458,779 units of Rosuvastatin Calcium 40 mg tablets, with a completion date of January 29, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award, valued at $59,871.71, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,565,618,267 units of rosuvastatin calcium 40 mg tablets over a period ending on August 29, 2024. This is a firm-fixed-price delivery order contract, with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) for the supply of Rosuvastatin Calcium 40 mg tablets. The $203,677.65 firm-fixed-price delivery order contract has a period of performance through May 9, 2023. No set-aside designation was used for this award. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, valued at $17,373.99, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Rosuvastatin Calcium 5 mg tablets in quantities of 500 tablets, with a completion date of April 18, 2023. This is a firm-fixed-price delivery order contract, with no set-aside designation. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,668.55 firm fixed-price delivery order contract covers the supply of 500 count bottles of 5 mg Rosuvastatin Calcium tablets. The contract has an ultimate completion date of July 30, 2024. This award is a child contract under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen...
This federal contract award, identified as SPE2DB20D2014|SPE2DB24FA26F, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,228.46 firm fixed-price delivery order is for the supply of 500 units of Rosuvastatin Calcium 40 mg tablets. The award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $2,259.72, is a delivery order for the medication Crestor 40 mg tablet, with a completion date of February 24, 2025. The contract is a firm fixed-price arrangement with no set-aside designation. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $17,020.10 delivery order is for Rosuvastatin Calcium 5 mg tablets, a cardiovascular medication. This award falls under a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a wide range of pharmaceutical products and medical...
This federal contract award, with ID SPE2DX15D6044|SPE2DX24FCQUR, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp's Corporate Office Division. The $1,807.20 firm fixed price delivery order is for the provision of 4,564,288,624 units of Rosuvastatin Calcium 40 mg tablets. This award is not associated with a set-aside program. Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, holds a...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $26,023.34 firm fixed-price delivery order contract is for the supply of 4,564,414,347 units of Rosuvastatin Calcium 20 mg tablets. The contract has an ultimate completion date of April 29, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at...
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB24FHX46
    Delivery Order

This federal contract award is for the delivery of 500 tablets of Rosuvastatin Calcium 40 mg, a cardiovascular medication, to the Defense Logistics Agency (DLA). The $18,141.15 fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on June 25, 2022, with a completion date of June 26, 2024. The award is not designated as a set-aside contract.

AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.

Generated 5/17/25, 10:01 AM